169 related articles for article (PubMed ID: 17134697)
21. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents.
Lin Z; Lim S; Viani MA; Sapp M; Lim MS
Am J Pathol; 2001 Aug; 159(2):711-9. PubMed ID: 11485929
[TBL] [Abstract][Full Text] [Related]
22. Alterations in the p16(INK4a) and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts.
Noble JR; Zhong ZH; Neumann AA; Melki JR; Clark SJ; Reddel RR
Oncogene; 2004 Apr; 23(17):3116-21. PubMed ID: 14743210
[TBL] [Abstract][Full Text] [Related]
23. Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor.
Incles CM; Schultes CM; Kelland LR; Neidle S
Mol Pharmacol; 2003 Nov; 64(5):1101-8. PubMed ID: 14573759
[TBL] [Abstract][Full Text] [Related]
24. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.
Dickson MA; Hahn WC; Ino Y; Ronfard V; Wu JY; Weinberg RA; Louis DN; Li FP; Rheinwald JG
Mol Cell Biol; 2000 Feb; 20(4):1436-47. PubMed ID: 10648628
[TBL] [Abstract][Full Text] [Related]
25. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
[TBL] [Abstract][Full Text] [Related]
26. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
[TBL] [Abstract][Full Text] [Related]
27. Relief of p53-mediated telomerase suppression by p73.
Toh WH; Kyo S; Sabapathy K
J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
[TBL] [Abstract][Full Text] [Related]
28. hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.
Shen Y; Zhang YW; Zhang ZX; Miao ZH; Ding J
Cancer Biol Ther; 2008 Feb; 7(2):228-36. PubMed ID: 18059183
[TBL] [Abstract][Full Text] [Related]
29. Differences in telomerase activity and the effects of AZT in aneuploid and euploid cells in colon cancer.
Fang X; Hu T; Yin H; Yang J; Tang W; Hu S; Xu X
Int J Oncol; 2017 Aug; 51(2):525-532. PubMed ID: 28627647
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.
Peek GW; Tollefsbol TO
Exp Cell Res; 2016 May; 344(1):95-102. PubMed ID: 27017931
[TBL] [Abstract][Full Text] [Related]
31. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
[TBL] [Abstract][Full Text] [Related]
32. Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
Cheng W; Wei Z; Gao J; Zhang Z; Ge J; Jing K; Xu F; Xie P
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):391-6. PubMed ID: 20556588
[TBL] [Abstract][Full Text] [Related]
33. Immortalization of bovine mammary epithelial cells alone by human telomerase reverse transcriptase.
Zhao CF; Hu HY; Meng L; Li QQ; Lin AX
Cell Biol Int; 2010 Apr; 34(6):579-86. PubMed ID: 20175753
[TBL] [Abstract][Full Text] [Related]
34. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
[TBL] [Abstract][Full Text] [Related]
35. Regulation of telomerase and its hTERT messenger in colorectal cancer.
Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
[TBL] [Abstract][Full Text] [Related]
36. Regulation of telomerase activity by the p53 family member p73.
Beitzinger M; Oswald C; Beinoraviciute-Kellner R; Stiewe T
Oncogene; 2006 Feb; 25(6):813-26. PubMed ID: 16205639
[TBL] [Abstract][Full Text] [Related]
37. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; CatricalĂ C; O'Toole KM
Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines.
George J; Banik NL; Ray SK
Int J Biochem Cell Biol; 2010 Jul; 42(7):1164-73. PubMed ID: 20394835
[TBL] [Abstract][Full Text] [Related]
39. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway.
Wang Z; Kyo S; Takakura M; Tanaka M; Yatabe N; Maida Y; Fujiwara M; Hayakawa J; Ohmichi M; Koike K; Inoue M
Cancer Res; 2000 Oct; 60(19):5376-81. PubMed ID: 11034074
[TBL] [Abstract][Full Text] [Related]
40. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
